Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 714K
2: EX-10.1 Material Contract HTML 26K
3: EX-10.2 Material Contract HTML 23K
4: EX-10.3 Material Contract HTML 24K
5: EX-12.1 Statement re: Computation of Ratios HTML 29K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 33K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
14: R1 Document and Entity Information Document HTML 37K
15: R2 Condensed Consolidated Balance Sheets HTML 118K
16: R3 Condensed Consolidated Balance Sheet HTML 34K
(Parenthetical)
17: R4 Condensed Consolidated Statements of Operations HTML 87K
18: R5 Condensed Consolidated Statements of Comprehensive HTML 56K
Income
19: R6 Condensed Consolidated Statements of Changes in HTML 87K
Equity
20: R7 Condensed Consolidated Statements of Cash Flows HTML 105K
21: R8 Basis of Presentation (Notes) HTML 34K
22: R9 Investments (Notes) HTML 222K
23: R10 Fair Value (Notes) HTML 182K
24: R11 Other Current Receivables (Notes) HTML 24K
25: R12 Medical Costs Payable (Notes) HTML 40K
26: R13 Commercial Paper and Long-Term Debt (Notes) HTML 205K
27: R14 Shareholders' Equity (Notes) HTML 30K
28: R15 Commitments and Contingencies (Notes) HTML 30K
29: R16 Segment Financial Information (Notes) HTML 311K
30: R17 Basis of Presentation Basis of Presentation HTML 45K
(Policies)
31: R18 Investments Investments (Policies) HTML 23K
32: R19 Investments (Tables) HTML 219K
33: R20 Fair Value (Tables) HTML 182K
34: R21 Medical Costs Payable (Tables) HTML 40K
35: R22 Commercial Paper and Long-Term Debt (Tables) HTML 205K
36: R23 Shareholders' Equity (Tables) HTML 28K
37: R24 Segment Financial Information (Tables) HTML 310K
38: R25 Basis of Presentation Basis of Presentation, Uses HTML 27K
of Estimates and Significant Accounting Policies
(Details)
39: R26 Investments (Narrative) (Details) HTML 25K
40: R27 Investments (Short-Term and Long-Term Investments) HTML 84K
(Details)
41: R28 Investments (Amortized Cost and Fair Value of HTML 92K
Available-for-Sale Debt Securities by Contractual
Maturity) (Details)
42: R29 Investments (Fair Value of Available-For-Sale HTML 62K
Investments with Gross Unrealized Losses by
Investment Type and Length of Time That Individual
Securities Have Been in a Continuous Unrealized
Loss Position) (Details)
43: R30 Fair Value (Narrative) (Details) HTML 36K
44: R31 Fair Value (Financial Assets and Liabilities HTML 84K
Measured at Fair Value on a Recurring Basis)
(Details)
45: R32 Fair Value (Financial Assets and Liabilities, Not HTML 78K
Measured at Fair Value on a Recurring Basis)
(Details)
46: R33 Other Current Receivables (Details) HTML 22K
47: R34 Medical Costs Payable (Narrative) (Details) HTML 20K
48: R35 Medical Costs Payable Rollforward (Details) HTML 42K
49: R36 Commercial Paper and Long-Term Debt (Narrative) HTML 69K
(Details)
50: R37 Commercial Paper and Long-Term Debt (Details) HTML 163K
51: R38 Commercial Paper and Long-Term Debt Subsequent HTML 37K
Events (Details)
52: R39 Shareholders' Equity (Details) HTML 23K
53: R40 Commitments and Contingencies (Details) HTML 32K
54: R41 Segment Financial Information (Narrative) HTML 27K
(Details)
55: R42 Segment Financial Information (Details) HTML 99K
57: XML IDEA XML File -- Filing Summary XML 97K
56: EXCEL IDEA Workbook of Financial Reports XLSX 65K
8: EX-101.INS XBRL Instance -- unh-20170930 XML 3.70M
10: EX-101.CAL XBRL Calculations -- unh-20170930_cal XML 190K
11: EX-101.DEF XBRL Definitions -- unh-20170930_def XML 633K
12: EX-101.LAB XBRL Labels -- unh-20170930_lab XML 1.35M
13: EX-101.PRE XBRL Presentations -- unh-20170930_pre XML 803K
9: EX-101.SCH XBRL Schema -- unh-20170930 XSD 126K
58: ZIP XBRL Zipped Folder -- 0000731766-17-000045-xbrl Zip 217K
Our director compensation and benefit program is designed to compensate our non-employee directors fairly for work required for a company of our size and scope, and align their interests with the long-term interests of our shareholders. Director compensation reflects our desire to attract, retain and use the expertise of highly qualified people serving on the Company’s Board of Directors. The Compensation and Human Resources Committee reviews the compensation level of our non-employee directors on an annual basis and makes recommendations to the Board
of Directors.
The Company uses annual retainers, equity-based compensation, expense reimbursement and other forms of compensation, as appropriate, to attract and retain non-employee directors.
Cash Compensation
Non-employee directors receive an annual cash retainer of $125,000. We pay an additional annual cash retainer of $300,000 to the Chair of the Board, an additional annual cash retainer of $75,000 to the Lead Independent Director, an additional annual cash retainer of $25,000 to the Chair of the Audit Committee, and additional annual cash retainers of $20,000 to the Chairs of the Compensation and Human Resources Committee, the Nominating and Corporate Governance Committee, and the Public Policy Strategies and Responsibility Committee.
Cash
retainers are payable on a quarterly basis in arrears on the first business day following the end of each fiscal quarter, and subject to pro-rata adjustment if the director did not serve the entire quarter. Directors may elect to receive deferred stock units (“DSUs”) in lieu of their cash compensation or defer receipt of their cash compensation to a later date pursuant to the Directors' Compensation Deferral Plan ("Director Deferral Plan").
Equity-Based Compensation
Non-employee directors receive annual grants of DSUs under the 2011 Stock Incentive Plan, as amended, having an annual aggregate fair value of $175,000. The grants are issued quarterly in arrears on the first business day following the end of each fiscal quarter and prorated if the director did not serve the entire quarter. The number of DSUs granted is determined by dividing $43,750 (the quarterly value of
the annual equity award) by the closing stock price on the grant date, rounded up to the nearest share.
The DSUs immediately vest upon grant, and non-employee directors who have not met the stock ownership requirement are required to retain all DSUs granted until completion of their service on the Board of Directors. Upon completion of service, the DSUs convert into an equal number of shares of the Company’s common stock. A director may defer receipt of the shares for up to ten years after completion of service pursuant to the Director Deferral Plan. Non-employee directors who have met their stock ownership requirement may elect to receive common stock in lieu of DSUs and/or in-service distributions on pre-selected dates.
If a director elects to convert his or her cash compensation into DSUs, such conversion grants are made on the day the eligible cash compensation becomes payable to the director and immediately vest upon grant. The director receives the number of DSUs equal to the cash compensation foregone, divided by the closing price of our common stock on the date of grant, rounded up to the nearest share.
The Company pays dividend equivalents in the form of additional DSUs on all outstanding DSUs. Dividend equivalents are paid at the same rate and at the same time that dividends are paid to Company shareholders and are subject to the same vesting conditions
as the underlying grant.
Director Deferral Plan
Under the Director Deferral Plan, subject to compliance with applicable laws, non-employee directors may elect annually to defer receipt of all or a percentage of their compensation. Amounts deferred are credited to a bookkeeping account maintained for each director participant that uses a collection of unaffiliated mutual funds as measuring investments. Subject to certain additional rules set forth in the Director Deferral Plan, a participating director may elect to receive the distribution in one of the following ways:
•
a series of five or ten annual installments following the completion of his or her service on the Board of Directors;
•
a
delayed lump sum following either the fifth or tenth anniversary of the completion of his or her service on the Board of Directors;
•
for cash deferrals, an immediate lump sum upon the completion of his or her service on the Board of Directors; or
•
pre-selected amounts to be distributed on pre-selected dates while the director remains a member of the Board of Directors.
The Director Deferral Plan does not provide for matching contributions by the
Company.
Other Compensation
We reimburse directors for any out-of-pocket expenses incurred in connection with service as a director. We also provide health care coverage to directors but only if the director is not eligible for coverage under another group health care benefit program. Health care coverage is provided generally on the same terms and conditions as current employees. Upon retirement from the Board of Directors, current directors may continue to obtain health care coverage under benefit continuation coverage, and after the lapse of such coverage, under the Company’s post-employment medical plan for up to a total of 96 months if they are otherwise eligible.
The
Company maintains a program through which it will match up to $15,000 of charitable donations made by each director for each calendar year. The directors do not receive any financial benefit from this program because the charitable income tax deductions accrue solely
to the Company. Donations under the program may not be made to family trusts, partnerships or similar organizations.
Stock Ownership Guidelines
We require non-employee directors to achieve ownership of shares
of the Company’s common stock (including DSUs) having a fair market value equal to five times the directors’ annual base cash retainer. Non-employee directors must comply with the stock ownership guidelines within five years of appointment to the Board.
